期刊文献+

血浆BNP浓度在老年患者麻醉风险体系评估中的临床意义 被引量:3

Clinical Significance of Plasma BNP Levels in Elderly Patients with Anesthetic Risk Assessment System
下载PDF
导出
摘要 目的:研究血浆BNP浓度在老年患者麻醉风险体系评估中的临床意义。方法:选用美国麻醉医师协会(ASA)的病情评估分级标准,对198例老年患者进行相关手术风险评估。结果:血浆BNP浓度和ASA手术麻醉风险之间为正相关关系。结论:血浆BNP浓度对于老年人手术风险评估有一定的参考意义,值得临床采用。 Objective:To study the plasma BNP levels in elderly patients with anesthetic risk assessment system,the clinical significance.Methods:American Society of Anesthesiologists(ASA) classification of disease assessment criteria,198 cases of elderly patients with surgery-related risk assessment.Results:Plasma BNP concentration and the risk of anesthesia between the ASA positive correlation.Conclusion:Plasma BNP concentration risk assessment procedure for older people have a certain reference value,worthy of clinical use.
作者 向登国 田华
出处 《中国医药导刊》 2011年第12期2039-2040,共2页 Chinese Journal of Medicinal Guide
关键词 血浆BNP 麻醉风险评估 老年人 Plasma BNP Anesthesia risk assessment Elderly
  • 相关文献

参考文献7

  • 1McKenna K,,Smith D,Moore K,et al.Btype natriuretic peptide increases urinary albumin and alpha-1 microglobulin excretion in type I diabetes mellitus[].Diabetic Medicine.2010
  • 2Loran DB,,Hyde BR,Zwischenberger JB.Perioperativemanagement of special populations:the geriatricpatient[].Surgical Oncology Clinics of North America.2005
  • 3林杰,郑德琳,李庭富.心力衰竭患者血浆脑钠素浓度与心功能的关系[J].临床心血管病杂志,2001,17(10):454-455. 被引量:42
  • 4Cowie MR,Mendez GF.BNP and congestive heart failure[].Progress in Cardiovascular Diseases.2010
  • 5Maisel AS,McCullough PA.Cardiac natriuretic peptides:a proteomic window to cardiac function and clinical management[].Reviews in Cardiovascular Medicine.2011
  • 6Nishikimi T,Maeda N,Matsuoka H.The role of natriuretic peptides in cardioprotectionr[].Cardiovascular Research.2006
  • 7Sudoh T,Kangawa K,Minamino N,et al.A new natriuretic peptide in procine brain[].Nature.1988

二级参考文献7

  • 1[1]Bettencourt P, Ferreira A, Dias P, et al. Evaluation of brain natriuretic peptide in the diagnosis of heart failure. Cardiology, 2000,93(1~2): 19-25.
  • 2[2]Mukoyama M, Nakao K, Saito Y, et al. Increased human brain natriuretic peptide in congestive heart failure. N Engl J Med, 1990,323: 757-758.
  • 3[3]Raine A E G, Erne P, Burgisser E, et al. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med, 1986,315: 533-537.
  • 4[4]Yoshimura M, Yasue H, Okumura K, et al. Different secretion pattern of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation, 1993,87: 464-469.
  • 5[5]Yasue H, Yoshimura M, Sumida H, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation, 1994,90: 195-203.
  • 6[6]Hama N, Itoh H, Shirakami G, et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation, 1995,92: 1558-1564.
  • 7[7]Arakawa N, Nakamura M, Aoki H, et al. Relati-onship between plasma level of brain natriuretic peptide and myocardial infarct size. Cardiology, 1994,85:334-340.

共引文献41

同被引文献30

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部